MRIによる前立腺の体積測定について-TRUS,CT,MRIの比較

I-125 permanently implanted sealed-source radiotherapy is one of the treatments for early localized prostate carcinoma. In order to choose treatment parameters such as the number of implanted sources, accurately determining the volume of the prostate is vital for this type of therapy. We compared th...

Full description

Saved in:
Bibliographic Details
Published in日本放射線技術学会雑誌 Vol. 64; no. 11; pp. 1369 - 1374
Main Authors 野田, 主税, 高橋, 俊行, 加藤, 京一, 斉藤, 肇, 中澤, 靖夫, 岡部, 圭吾
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本放射線技術学会 2008
Subjects
Online AccessGet full text
ISSN0369-4305
1881-4883
DOI10.6009/jjrt.64.1369

Cover

More Information
Summary:I-125 permanently implanted sealed-source radiotherapy is one of the treatments for early localized prostate carcinoma. In order to choose treatment parameters such as the number of implanted sources, accurately determining the volume of the prostate is vital for this type of therapy. We compared the usefulness of transrectal ultrasound (TRUS), computed tomography (CT), and magnetic resonance imaging (MRI) for preoperative stereometry of the prostate, and we further reviewed the utility of the MRI measurement. We performed prostate stereometry with TRUS, CT, and MRI in each of 45 patients who had provided informed consent. Taking TRUS stereometry as the standard, we computed the correlation of the MRI results with TRUS, and that of the CT results with TRUS, and found that MRI had a higher correlation.
ISSN:0369-4305
1881-4883
DOI:10.6009/jjrt.64.1369